Iconovo AB (publ.), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announces that it has agreed to conduct a feasibility study on behal ...
About Kinaset Therapeutics, Inc. Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. With founding investors 5AM ...
This form of rapid-acting inhaled insulin, recently introduced in India by the name Afrezza, is said to offer an important ...